| Sofosbuvir plus daclatasvir in treatment of chronic hepatitis C genotype 4 infection in a cohort of Egyptian patients: an experiment the size of Egyptian village OA Ahmed, E Safwat, MO Khalifa, AI Elshafie, MHA Fouad, MM Salama, ... International journal of hepatology 2018, 2018 | 96 | 2018 |
| Outcomes and predictors of treatment response with sofosbuvir plus daclatasvir with or without ribavirin in Egyptian patients with genotype 4 hepatitis C virus infection OA Ahmed, MA Elsebaey, MHA Fouad, H Elashry, AI Elshafie, ... Infection and Drug Resistance 11, 441—445, 2018 | 63 | 2018 |
| Efficacy and safety of sofosbuvir-ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection OA Ahmed, HH Kaisar, R Badawi, N Hawash, H Samir, SST Shabana, ... Infection and Drug Resistance, 295-298, 2018 | 49 | 2018 |
| Efficacy of sofosbuvir plus ribavirin with or without peginterferon-alfa in treatment of a cohort of Egyptian patients with hepatitis C virus infection O A Ahmed, H H Kaisar, N Hawash, H Samir, S ST Shabana, ... Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious …, 2017 | 41 | 2017 |
| Retreatment of chronic hepatitis C patients who failed previous therapy with directly acting antivirals: A multicenter study M El Kassas, M Alboraie, M El Badry, N Youssef, H Omar, RY El Sheemy, ... International Journal of Infectious Diseases 96, 367-370, 2020 | 6 | 2020 |
| Outcomes of treatment and predictors of response to sofosbuvir plus simeprevir in hepatitis c virus with genotype-4 infection OA Ahmed, MA Elsebaey, MHA Fouad, M Elkadeem, R Badawi, ... Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious …, 2020 | 5 | 2020 |
| Serum alpha-fetoprotein levels and response to direct antiviral therapy in patients with chronic hepatitis C: real-world results from 1716 patients in Egypt R Badawi, M Alboraie, S Abd-Elsalam, MZ Abourahma, HK Ramadan, ... Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2019 | 5 | 2019 |
| Zinc deficiency correlates to spontaneous bacterial peritonitis in patients with cirrhotic ascites MA Hanna, MHA Fouad, AM ElGhandour, HH Ali The Egyptian Journal of Internal Medicine 31, 73-77, 2019 | 2 | 2019 |
| Platelet count/prothrombin time ratio as a noninvasive predictor for esophageal varices in Egyptian patients with hepatitis C virus-related liver cirrhosis MHA Fouad, AI Elshafie, TAR Ali, M Hassany, AH Soliman, HM Nasser Egyptian Liver Journal 8 (2), 68-71, 2018 | 2 | 2018 |
| Value of serum CA 19-9 in obstructive jaundice MO Khalifa, OA Ahmed, MHA Fouad, MAEKA Deif, MA Mansour Egyptian Liver Journal 6 (3), 54-60, 2016 | 2 | 2016 |
| Detection of HCV RNA by PCR in peripheral blood mononuclear cells as a predictor of relapse after antiviral therapy in Egyptian patients with chronic hepatitis C genotype 4 M Mohamed Yassen Moustafa, S El Sayed Mohamed Taha, ... QJM: An International Journal of Medicine 111 (suppl_1), hcy200. 116, 2018 | | 2018 |
| The role of fecal calprotectin in diagnosing inflammatory bowel disease and detecting disease activity EAM El-Fekhfakh, MO Khalifa, AM El Breedy, HEM Salem, ... Egyptian Liver Journal 8 (4), 136-142, 2018 | | 2018 |
| The effect of the degree of hepatitis C-related fibrosis on the responsiveness to pegylated interferon α-2a versus pegylated interferon α-2b: Egyptian study YM El Shazly, MAH El Bokl, MAM Mostafa, NA Adel, MO Khalifa, ... Egyptian Liver Journal 6 (2), 25-29, 2016 | | 2016 |
| • Effect of Prolongation of Combined Treatment in HCV-4 Infection R Al Swaff | | 2013 |
